AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹259 Cr | ₹131 Cr | ₹85 Cr | ₹73 Cr | - |
What is the latest Total Non-Current Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹259 Cr |
| Mar2024 | ₹131 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | - |
How is Total Non-Current Liabilities of AARTI PHARMALABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹259 Cr | 98.54 | |
| Mar2024 | ₹131 Cr | 53.89 | |
| Mar2023 | ₹85 Cr | 16.71 | |
| Mar2022 | ₹73 Cr | 0 | |
| Mar2021 | - | - | |
Compare Total Non-Current Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,249.2 Cr | 5.6% | -2.5% | -8.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 5.6% |
-2.5% |
-8.9% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses